1 / 30

Endocrine Review I Diabetes Mellitus

Endocrine Review I Diabetes Mellitus. Ana Corona, MSN, FNP-C Nursing Instructor July 2007 More presentations at: www.nurseana.com. Diabetes Mellitus. Disorder of carbohydrate metabolism Deficiency or resistance to insulin Characterized by hyperglycemia

tuan
Télécharger la présentation

Endocrine Review I Diabetes Mellitus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Endocrine Review IDiabetes Mellitus Ana Corona, MSN, FNP-C Nursing Instructor July 2007 More presentations at: www.nurseana.com

  2. Diabetes Mellitus • Disorder of carbohydrate metabolism • Deficiency or resistance to insulin • Characterized by hyperglycemia • Insulin dependent diabetes mellitus • Non-insulin dependent diabetes mellitus

  3. Symptoms of Diabetes Mellitus • 3 polys: • Polyuria • Polydypsia • Polyphasia • Weight loss (glucose not being used) • Fatigue • Recurrent infections (actual diagnosis)

  4. Age 45 every 3 years 120 fasting check in 6 months Management: Education Diet Carbohydrates 50% Fats 30% Protein 20% Meds Exercise High body mass Obese Over age 45 Hx GDM 70% DM 16 yrs FMH of DM DM Screening

  5. Diagnosis: 126 FBS repeat still 126 2 hr GTT >200 Confirmed on consequent day Laboratory: Complete metabolic panel (BUN & Creat) Urine microalbuminuria Small amounts of protein dump in urine Earliest manifestation of renal disease HbA1c - Glycosolated hemoglobin (not for DX used for status of patient) Lipid Panel Diagnosis DM guidelines

  6. DM Effects • Elevated BP • Renal Failure • Vascular Insufficiency • Fungal infections • Acanthosis nigrecans (dark/rough) • Parasthesias • Monofilament test • Foot care (peripheral neuropathy) • Eye Care (retinal hemorrhages, microaneurisms) • Dm does not affect Respiratory System

  7. Impaired Glucose Tolerance Mechanism • Body senses when you eat, the blood sugar goes up too high • What the body does it says “look this is too high” I need to produce more insulin • Pancreas starts to secret insulin • Initially early in the course of the disease type 2 DM patients have elevated insulin levels • Pancreas is pumping up more and more insulin • Pancreas runs out of juice and cannot produce any more insulin • End or the disease will get absence of insulin • Too much insulin, too little or absence of insulin

  8. DM I • Children • Young Adults • Destruction of the beta cells in the pancreas • Destroy beta cells in pancreas 3 very noticeable things happen: • Insulin deficiency and absence • Early start with insulin deficiency • then pancreas doesn’t put out any insulin at all

  9. Three polys Weight loss Fruity smell Hyperglycemia remarkable in children and young adults Glucose levels in 1200 or higher Glucose in urine because body is dumping it there. Acute presentation DM I Treatment: Education Diet Exercise Insulin DM I

  10. DM II • Dm discovered on routine exam • Decreased peripheral glucose utilization • Increase hepatic glucose production • Insufficient pancreatic secretion Treatment: • Education • Diet • Exercise • Medications

  11. 60 mg/dl with signs & symptoms: Cool moist skin Tremor Confusion Tachycardia Seizure Diaphoresis Anxiety hunger Blurred vision Lethargy Headache Confusion Paralysis Seizures Loc Irreversible brain damage to death Hypoglycemia

  12. Hypoglycemia Treatment • 10-15 grams carbohydrate every 15 mins until s/s disappear • Lifesaver candy or orange juice • Can’t swallow: glucagon injection • 0.5 mg. under age 3 IM • 1.0 mg adults IM • ER: 25 grams dextrose IV

  13. Hyperglycemia • 115 mg/dl • 300 mg/dl severe • Glycolysis • Sweet breath odor • Kussmauls breaths • Ketonuria • Ketosis, acidosis, tissue breakdown • Dehydration • Abdominal pain, n/v, fatigue, weight loss • 300 mg/dl • Ketones in urine • Low blood ph

  14. Dawn Phenomenon The dawn phenomenon occurs when: • Hormones (growth hormone, cortisol, and catecholamines) produced by the body cause the liver to release large amounts of sugar (glucose) into the bloodstream. • These hormones are released in the early morning hours. • These hormones also may partially block the effect of insulin, whether it's insulin your body produces or insulin from the last injection.

  15. Dawn Phenomenon • If the body doesn't produce enough insulin (which occurs in people with type 1 diabetes and a few people with type 2 diabetes), blood sugar levels may rise. This may cause high blood sugar in the morning before the person eats.

  16. Dawn Phenomenon • If the blood sugar level is normal or high at 2 a.m. to 3 a.m., it's likely the dawn phenomenon.

  17. Somogyi Phenomenon • The Somogyi effect can occur when a person takes long-acting insulin for diabetes. • If the blood sugar level drops too low in the early morning hours, hormones (such as growth hormone, cortisol, and catecholamines) are released. • These help reverse the low blood sugar level but may lead to blood sugar levels that are higher than normal in the morning.

  18. Somogyi Effect Example: • A person who takes insulin doesn't eat a regular bedtime snack, and the person's blood sugar level drops during the night. • A person's body responds to the low blood sugar in the same way as in the dawn phenomenon, by causing a high blood sugar level in the early morning.

  19. Somogyi Phenomenon • If the blood sugar level is low at 2 a.m. to 3 a.m., suspect the Somogyi effect.

  20. Insulins Very short acting Short acting Intermediate Long acting premix Oral Hypoglycemic Agents Non-Insulin Dependent Diabetes Mellitus NIDDM DM Type 2 DM Medications

  21. Insulin • Regular insulin is short acting will start working in 15 minutes to ½ an hour • Peak 2 – 4 hrs • Intermediate Insulin example NPH • Takes longer to start • Peak 6 – 8 hrs. • Combination Insulin 70/30 • When mixing short- and long-acting insulins in the same syringe, draw up the short-acting insulin first and then the long-acting insulin.

  22. Kick the pancreas to secret more insulin Hypoglycemia Weight gain Cheap med 1st generation Orinase Tolinase Diabinase 2nd generation Glipizide (glucotrol) Glimeprid (amaryl) Glyburide (micronase) Oral Hypoglycemic AgentsSulfonylureas

  23. Biguanides METFORMIN (glucophage) • Decreases production of glucose in the liver • Improves insulin sensitivity • Insulin on board will work a little better • No hypoglycemia Side Effects: • Flatulence and diarrhea • Weight Loss • Renal hepatic dysfunction • Monitor LFTs, Creatinine level • No alcohol – lactic acidosis (fatal)

  24. Alpha-glucosidase Inhibitors • Acarbose (Precose) • Miglitol (Glyset) • Take with meals • Slow carbs absorption from gut • Flatulence and diarrhea (3 wks)

  25. Thiazolidenediones • Avandia (rosiglitazone) • Actos (pioglitazone) • Monitor LFTs • Avandia monitor for heart failure • Makes body much more sensitive to insulin that’s already there • Not excreted by kidneys

  26. Diabetes Mellitus Complications 1. Diabetic Ketoacidosis (DKA) 2. Hyperosmolar Hyperglycemia Nonketotic Syndrome (HHNS)

  27. Severe hyperglycemia Dehydration Tachycardia Kussmals respirations (trying to blow off the acid) Metabolic acidosis from ketone breakdown Acetone breath Decreased level of consciousness Intestinal paralysis Pco2 < 35 mm/h Bicarb <28 Ph <7.35 acidosis IV to replace fluids (Normal Saline) Regular insulin IV Monitor glucose and electrolytes (potassium) High Potassium Level will lower rapidly with IV insulin watch for low potassium level Adding Potassium to IV may be necessary Regular Insulin only insulin given IV Diabetic Ketoacidosis (DKA)

  28. NIDDM Hyperglycemia with no ketones 800mg/dl Over age 60 No metabolic acidosis Severe Dehydration Tachycardia seizures Decreased level of consciousness Hallucinations Comatose Elderly Taking Oral hypoglycemic Renal insufficiency Treatment: IV Fluids Insulin Hyperosmolar Hyperglycemia Nonketotic Syndrome (HHNS)

  29. Nursing Diagnosis • Ineffective individual coping • Non-compliance • Altered nutrition: more than body requirements • Altered peripheral tissue perfusion • Altered urinary elimination • Anticipatory grieving • Fluid volume deficit • High risk for infection • High risk for injury • Hopelessness • Knowledge deficit • Sensory or perceptual alterations (visual)

  30. Nursing Interventions • Keep accurate records of vital signs, fluid intake/output, caloric intake • Monitor serum glucose levels • Monitor for acute complications • Provide meticulous skin care • Observe for signs of UTI, vaginal infections and other infections • Monitor for signs of diabetic neuropathy • Stress importance of proper treatment regimen

More Related